-
PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives
BOSTON, Feb. 6, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Ramita Tandon, Global Head, Late Phase Clinical Trials and Lars-Olof Eriksson, Ph.D., MS.c., Vice President, Global...
-
Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion
MOSCOW, Feb. 6, 2012 /PRNewswire/ -- Russia's first Leksell Gamma Knife® Perfexion™ system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow's Red Square. On June 2, 2011, a 59-year-old woman was...
-
BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne™ Leukemia Vaccine
BOTHELL, Wash., Feb. 6, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, today recognized its customer...
-
CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015
ALBANY, New York, February 6, 2012 /PRNewswire/ --
In the news release, "Global Osteoporosis Market is Expected to Attain a Market Size of USD 6.8 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015" issued on 31 Jan 2012 11:30 GMT, by Transparency Market...
-
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference
BLUE BELL, Pa., Feb. 6, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that Dr. J. Joseph Kim, President and CEO, will present an overview of the company at the 14th Annual BIO CEO and Investor Conference.
BIO CEO & Investor Conference...
-
Neue Studien zeigen, dass der Verzehr von Obst wichtiger für die männliche Attraktivität ist als Maskulinität
CAMBRIDGE, England, February 6, 2012 /PRNewswire/ --
Neuesten Forschungsergebnissen zufolge hat der Verzehr von dunkelfarbenem und frischem Obst, wie Pflaumen, Pfirsiche und Nektarinen, mehr Einfluss darauf, wie attraktiv ein Mann erscheint als seine Maskulinität.
Dr. Ian Stephen...
-
TPI to Host Second Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, February 14, 2012 at 8:30 a.m. ET
CHENGDU, China, Feb. 5, 2012 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active...
-
Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma (mRCC)
DURHAM, N.C., Feb. 4, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that updated results from an open label Phase 2 study of its Arcelis™ immunotherapy, AGS-003, in combination with sunitinib in patients with unfavorable risk, metastatic renal...
-
St. Jude Children's Research Hospital Celebrates 50 Years
Tennessee Governor Proclaims February as St. Jude Month
MEMPHIS, Tenn., Feb. 4, 2012 /PRNewswire-USNewswire/ -- In 1962, St. Jude Children's Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. At that time, few...
-
Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida
DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA registration.
U.S. District Court for the District of Columbia...
-
Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives
NEW YORK, Feb. 3, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP today announced that it has filed a securities class action lawsuit against China Medical Technologies, Inc. ("China Medical" or the "Company") (NASDAQ: CMED) and certain of its senior executives. The action (No....
-
Pharmaceutical and Medical Device Companies Shift Medical Education Focus into Emerging Markets
CHAPEL HILL, N.C., Feb. 3, 2012 /PRNewswire/ -- In the current environment, medical education groups are faced with the challenge of holding down costs while adding new programs and expanding into emerging markets. As a result, pharmaceutical and medical device leaders are beginning...
-
Vita Needle Company Receives ISO 9001 and ISO 13485 Certifications
NEEDHAM, Mass., Feb. 3, 2012 /PRNewswire-iReach/ -- Vita Needle Company recently celebrated dual certifications of its Quality Management Systems to the latest general ISO 9001:2008 and medical device manufacturing standards ISO 13485:2003. In addition, the fifth generation...
-
Shifting Healthcare Landscape has put Medical Science Liaisons in Key Role as Relationship Builder for Pharmaceutical Industry
CHAPEL HILL, N.C., Feb. 3, 2012 /PRNewswire/ -- Medical Science Liaisons have become a key link between the pharmaceutical industry and key stakeholders such as thought leaders that drive marketplace success. And the role of MSLs will grow even more in the coming years as the...
-
Stryker stellt die Ergebnisse der prospektiven klinischen Studie TREVO auf der International Stroke Conference vor
KALAMAZOO, Michigan, February 3, 2012 /PRNewswire/ --
- Trevo® Pro System stellt gute funktionelle Resultate bei 55% der Patienten wieder her, die von einem schweren akuten ischämischen Schlaganfall betroffen sind
Am 2. Februar hat Stryker auf der Late-Breaking Science...
-
Kensey Nash to Present at the Canaccord Genuity's Musculoskeletal Conference
EXTON, Pa., Feb. 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012 at Parc 55 in San Francisco, California.
Joseph W. Kaufmann, Kensey Nash's President and CEO, will...
-
Buyout Offer for Micromet Triggers Shareholder-Claim Investigation by Goldfarb LLP Securities Attorneys
DALLAS, Feb. 3, 2012 /PRNewswire/ -- Securities lawyers at Goldfarb LLP are investigating whether certain officers and directors of Micromet, Inc. (NASDAQ: MITI) violated shareholder protection laws by agreeing to a tender offer for $11.00 per share to Amgen. Concerned Micromet...
-
Evergreen Neurologist Co-Authors New Study Linking Coffee, Genetics and Parkinson's Disease Prevention
KIRKLAND, Wash., Feb. 3, 2012 /PRNewswire/ -- A recent study co-authored by Evergreen Healthcare neurologist Dr. Pinky Agarwal finds good news for coffee drinkers: consuming caffeinated coffee may significantly reduce the risk of Parkinson's disease in some men and women...
-
Unity Management Group Announces Additions to Executive Management Team, Acquisition, and Additional Contracts
EAST HANOVER, N.J., Feb. 3, 2012 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) (or "the Company") announced today Dr. Michael Levin has joined its wholly owned subsidiary Metropolitan Computing Corporation (or MCC) to manage product development, develop new business, and...
-
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results
SHENYANG, China, Feb. 3, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its...
|